by PEAK Medicals | 17 July 2024
Chronic lymphocytic leukemia Welcome & introduction by host Noémie Lang Management of relapsed / refractory CLL Toby Eyre Immunotherapies in CLL: CAR T-cells & bispecifics Mascha Binder New treatment strategies for frontline CLL Noémie Lang  } 1 h 30 min Get Your CME...
by PEAK Medicals | 14 May 2024
DLBCL Debate: Bispecifics VS. CAR-T Welcome & introduction by host Maria Cristina Pirosa The case for CAR: why CAR T-cells can excel DLBCL care Federico Simonetta The case for Bispecifics: bispecific therapy can provide a dynamic approach to DLBCL management...
by PEAK Medicals | 24 May 2023
Chronic Lymphocytic Leukemia Welcome & introduction by host Davide Rossi Latest treatment strategies in frontline CLL George Follows Treatment sequencing in relapsed / recurrent CLL Nicole Lamanna Immunotherapies in CLL: CAR-T and bispecifics Davide Rossi  } 1 h 31...
by PEAK Medicals | 17 May 2023
Multiple Myeloma Welcome & introduction by host Mohamad Mohty What's new for induction in the transplant setting? Sonja Zweegman Current management of relapsed / recurrent myeloma Carmen de Ramon Ortiz Immunotherapies in myeloma: CAR-T and bispecifics Mohamad Mohty ...
by PEAK Medicals | 25 May 2022
Multiple Myeloma Welcome & introduction by host Mohamad Mohty Current SoC in 1L Multiple Myeloma (Transplant-Eligible and Non-Transplant-Eligible patients) Maria Victoria Mateos Multiple Myeloma Not Refractory to Lenalidomide Francesca Gay Multiple Myeloma Refractory...
